Playback speed
10 seconds
Best of ASCO® Los Angeles 2024: The PATHWay Trial - Adjuvant Pembro vs. Placebo in Patients With HNSCC at High Risk for Recurrence
By
UCLA Health
FEATURING
Deborah Wong
By
UCLA Health
FEATURING
Deborah Wong
112 views
September 19, 2024
Comments 0
Login to view comments.
Click here to Login
Recommended
AUTOPLAY